Jerrica Farias

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +4

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

James F. Howard, Vera Bril, Ted M. Burns et al. · Neurology · 2019 · 288 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Influence of Mindfulness-Based Stress Reduction (MBSR) on Telomerase Activity in Women With Breast Cancer (BC)

Cecile A. Lengacher, Richard R. Reich, Kevin E. Kip et al. · Biological Research For Nursing · 2014 · 170 citations · Full text

Medicine, Oncology, Radiation Oncology +16

The effects of mindfulness-based stress reduction on objective and subjective sleep parameters in women with breast cancer: a randomized controlled trial

Cecile A. Lengacher, Richard R. Reich, Carly L. Paterson et al. · Psycho-Oncology · 2014 · 119 citations · Full text

Medicine, Psychology, Behavioral Health +14

Baseline Immune Biomarkers as Predictors of MBSR(BC) Treatment Success in Off-Treatment Breast Cancer Patients

Richard R. Reich, Cecile A. Lengacher, Kevin E. Kip et al. · Biological Research For Nursing · 2014 · 38 citations

Medicine, Immunology, Oncology +17